Previous studies have reported that QQC played a role in the treatment of CHF through multiple mechanisms, such as reducing cardiac fibrosis remolding, improving cardiac function, reducing NT-proBNP, and regulating the inflammatory responses [13–16]. This evidence concerns the gene NPPB and congestive heart failure.